The DOI matches its Crossref record.
Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S).
Abstract
The derivation of subline of CTLL cells that grow in IL-4/B cell stimulatory factor-1 is described. These cells, designated CT.4R cells, were obtained by extended culture of the CTLL line CT.EV in IL-4. CT.4R cells are highly responsive to both IL-4 and IL-2. Mutagenesis of CT.4R cells with ethylmethane sulfonate and selection for lack of expression of the p55 chain of the IL-2R was carried out and a clone was selected that was hyporesponsive to IL-2 but retained full sensitivity to IL-4. These cells, designated CT.4S cells, develop a very meager response to IL-2 at concentrations of 100 U/ml or less although that display vigorous responses to higher IL-2 concentrations. CT.4S cells give measurable responses to 3-10 U/ml (approximately 15-50 pg/ml) of IL-4. CT.4R and CT.4S cells fail to respond to IL-1, IL-3, IL-6, granulocyte-macrophage-CSF, granulocyte-CSF, CSF-1 or IFN-gamma. Thus, CT.4S cells can be used as a sensitive and specific bioassay for IL-4. ID CT.4R cells can be grown in either IL-4 or IL-2. When grown in IL-4, CT.4R cells express small amounts of the p55 chain of the IL-2R but rapidly upregulate their level of expression of p55 when IL-2 is added and rapidly diminish p55 expression when IL-2 is removed. Thus, although IL-2 and IL-4 both stimulate vigorous growth responses by CT.4R cells, they differ in their capacity to induce the expression of the p55 chain implying that their mechanisms of T cell stimulation are not identical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
Plaut, M., Pierce, J. H., Watson, C. J., Hanley-Hyde, J., Nordan, R. P., & Paul, W. E. (1989) · Nature · doi:10.1038/339064a0 · Cited by 1,170
Self-citationInterleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-7 Receptor
Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., & Leonard, W. J. (1993) · Science · doi:10.1126/science.8266077 · Cited by 1,109
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Seder, R. A., Paul, W. E., Davis, M. M., & Fazekas de St Groth, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.1091 · Cited by 997
Self-citationSeder, R. A., Gazzinelli, R., Sher, A., & Paul, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10188 · Cited by 976
Self-citationLe Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954
Self-citationInterleukin-4: a prototypic immunoregulatory lymphokine
Paul, W. (1991) · Blood · doi:10.1182/blood.v77.9.1859.1859 · Cited by 880
Self-citationYoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Self-citationYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
Scharton, T. M., & Scott, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.567 · Cited by 608
Interleukin-2 Receptor γ Chain: a Functional Component of the Interleukin-4 Receptor
Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E., et al. (1993) · Science · doi:10.1126/science.8266078 · Cited by 605
Self-citationRapoport, M. J., Jaramillo, A., Zipris, D., Lazarus, A. H., Serreze, D. V., Leiter, E. H., Cyopick, P., Danska, J. S., & Delovitch, T. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.1.87 · Cited by 507
Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C. W., Wynn, T. A., & Shearer, G. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116294 · Cited by 469
The phenotype of murine wound macrophages
Daley, J. M., Brancato, S. K., Thomay, A. A., Reichner, J. S., & Albina, J. E. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409236 · Cited by 452
Induction of Protective CTL Responses in Newborn Mice by a Murine Retrovirus
Sarzotti, M., Robbins, D. S., & Hoffman, P. M. (1996) · Science · doi:10.1126/science.271.5256.1726 · Cited by 446
Joosten, L. A. B., Lubberts, E., Durez, P., Helsen, M. M. A., Jacobs, M. J. M., Goldman, M., & van den Berg, W. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400209 · Cited by 397
Lehuen, A., Lantz, O., Beaudoin, L., Laloux, V., Carnaud, C., Bendelac, A., Bach, J.-F., & Monteiro, R. C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1831 · Cited by 393
Cong, Y., Brandwein, S. L., McCabe, R. P., Lazenby, A., Birkenmeier, E. H., Sundberg, J. P., & Elson, C. O. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.855 · Cited by 383
Actor, J. K., Shirai, M., Kullberg, M. C., Buller, R. M., Sher, A., & Berzofsky, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.948 · Cited by 353
Carson, W. E., Ross, M. E., Baiocchi, R. A., Marien, M. J., Boiani, N., Grabstein, K., & Caligiuri, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118321 · Cited by 348
Noben-Trauth, N., Shultz, L. D., Brombacher, F., Urban, J. F., Gu, H., & Paul, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10838 · Cited by 344
Self-citationActivation events during thymic selection.
Bendelac, A., Matzinger, P., Seder, R. A., Paul, W. E., & Schwartz, R. H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.731 · Cited by 319
Self-citationDistinct types of lung disease caused by functional subsets of antiviral T cells.
Alwan, W. H., Kozlowska, W. J., & Openshaw, P. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.81 · Cited by 316
Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R., & Clifford, K. N. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06715.x · Cited by 283
Induction of Autoimmune Valvular Heart Disease by Recombinant Streptococcal M Protein
Quinn, A., Kosanke, S., Fischetti, V. A., Factor, S. M., & Cunningham, M. W. (2001) · Infection and Immunity · doi:10.1128/iai.69.6.4072-4078.2001 · Cited by 151
UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses
Garssen, Vandebriel, Gruijl, D., Wolvers, Dijk, V., Fluitman, & Loveren, V. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00801.x · Cited by 119
Immunological Consequences of In Vitro Exposure to Lysergic Acid Diethylamide (LSD)
House, R. V., Thomas, P. T., & Bhargava, H. N. (1994) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979409029898 · Cited by 43
Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro
Jung, T., Wagner, K., Neumann, C. R., & Heusser, C. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<864::aid-immu864>3.0.co;2-t · Cited by 37
Pizzoferrato, E., Chu, N. R., Hawley, T. S., Lieu, F. H. L., Barber, B. H., Hawley, R. G., Watts, T. H., & Berinstein, N. L. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.18-2217 · Cited by 28
Metadata
- Authors
- Hu-Li, J., Ohara, J., Watson, C., Tsang, W., & Paul, W. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-02-01
- Volume
- 142
- Issue
- 3
- Pages
- 800-807
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1555235592
- Cited by
- 279
- References
- 0
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.